Table 2.

Effect of IL-7 on Molecules Controlling IgE Synthesis

AStimulusCD21CD23-1CD23CD40CD40L
None 93% 54 42% 55 2% 53 99% 138 <1% 
IL-7 90% 53 46% 63 2% 98 99% 138 <1% 
IL-4 90% 54 71% 159 38% 110 99% 220 <1% 
IL-4 + IL-7 88% 53 74% 151 38% 107 99% 219 <1% 
AStimulusCD21CD23-1CD23CD40CD40L
None 93% 54 42% 55 2% 53 99% 138 <1% 
IL-7 90% 53 46% 63 2% 98 99% 138 <1% 
IL-4 90% 54 71% 159 38% 110 99% 220 <1% 
IL-4 + IL-7 88% 53 74% 151 38% 107 99% 219 <1% 
BStimulusIL-4IL-6IFNγs. CD23
None <0.1 76 ± 7 3.1 ± 0.2 2.4 ± 0.2 
IL-7 <0.1 112 ± 15 7.7 ± 1.2 3.8 ± 0.5 
IL-4 ND 13 ± 3 1.7 ± 0.4 8.9 ± 1.1 
IL-4 + IL-7 ND 26 ± 5 1.8 ± 0.3 23.6 ± 4.2 
BStimulusIL-4IL-6IFNγs. CD23
None <0.1 76 ± 7 3.1 ± 0.2 2.4 ± 0.2 
IL-7 <0.1 112 ± 15 7.7 ± 1.2 3.8 ± 0.5 
IL-4 ND 13 ± 3 1.7 ± 0.4 8.9 ± 1.1 
IL-4 + IL-7 ND 26 ± 5 1.8 ± 0.3 23.6 ± 4.2 

PBMCs were either unstimulated or stimulated with IL-4 and/or 10 ng/mL IL-7. (A) The B-cell surface expression of CD21, CD23, CD40, CD40L, and the binding of CD23-liposomes (CD23-I) was evaluated by FACS analysis at day 3. (B) Cytokines and sCD23 were quantified in 3-day supernatants. Results are expressed in ng/mL (mean ± SD of triplicate values). The percentage and the MFI of the positive B cells is reported. Data are representative of one of four experiments.

Abbreviations: ND, not done; MFI, mean fluorescence intensity.

or Create an Account

Close Modal
Close Modal